Verified Nov 2026
Other
·

Chiyoda City, Tokyo
·
Since 1963
Taiho Pharmaceutical Co., Ltd. is a Japanese specialty pharmaceutical company headquartered in Chiyoda City, Tokyo, founded in 1963. Employing 1,000–5,000 people with estimated revenue of $1–5 billion, it operates as a wholly owned subsidiary of Otsuka Holdings Co., Ltd. The company focuses on oncology, allergy and immunology, and urology, serving automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors. Recent activity includes completing an FDA filing for a first-line lung cancer combination therapy and entering a strategic partnership with Fujifilm for next-generation antibody-drug conjugate manufacturing.
Taiho Pharmaceutical Co., Ltd., at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
1963
Headquarters
Chiyoda City, Tokyo
Certifications
ISO 14001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & active
63 years in operation (founded 1963).
Holds ISO 14001 certification(s) per public sources.
Overview
Taiho Pharmaceutical Co., Ltd. is a Japanese specialty pharmaceutical company headquartered in Chiyoda City, Tokyo, founded in 1963. Employing 1,000–5,000 people with estimated revenue of $1–5 billion, it operates as a wholly owned subsidiary of Otsuka Holdings Co., Ltd. The company focuses on oncology, allergy and immunology, and urology, serving automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors. Recent activity includes completing an FDA filing for a first-line lung cancer combination therapy and entering a strategic partnership with Fujifilm for next-generation antibody-drug conjugate manufacturing.
At a glance
Attribute | Detail |
|---|---|
Founded | 1963 |
Headquarters | Chiyoda City, Tokyo |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
Certifications | ISO 14001 |
What Taiho Pharmaceutical Co., Ltd., makes
Taiho develops prescription oncology drugs and over-the-counter health products and holds ISO 14001 certification for environmental management.
Certifications
Taiho Pharmaceutical Co., Ltd., is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — taiho.co.jp
Latest developments
2026-11-13 — Cullinan Partner Taiho Completes FDA Filing For Zipalertinib Combo In First-Line Lung Cancer (rttnews.com)
2026-08-03 — Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies | Fujifilm [Japan] (fujifilm.com)
2026-04-27 — Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development (taihooncology.com)
2025-11-28 — JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information: Press Releases | NEC (nec.com)
2025-11-20 — Taiho Oncology, Taiho Pharmaceutical and Cullinan ... (prnewswire.com)
2025-10-19 — Arcus Biosciences - Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia (arcusbio.com)
Company details
As a subsidiary of Otsuka Holdings, the company maintains a global presence across the U.S., Europe, Asia, and Oceania and is recognized as an oncology player in Japan. Taiho Pharmaceutical Co., Ltd., was founded in 1963, has an estimated 1,000-5,000 employees, and is headquartered in Chiyoda City, Tokyo. On the LightSource stability read it is rated "Established & active": 63 years in operation (founded 1963). Holds ISO 14001 certification(s) per public sources.
Frequently asked questions
What does Taiho Pharmaceutical Co., Ltd., do?
Taiho Pharmaceutical Co., Ltd. is a Japanese specialty pharmaceutical company headquartered in Chiyoda City, Tokyo, founded in 1963. Employing 1,000–5,000 people with estimated revenue of $1–5 billion, it operates as a wholly owned subsidiary of Otsuka Holdings Co., Ltd. The company focuses on oncology, allergy and immunology, and urology, serving automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors. Recent activity includes completing an FDA filing for a first-line lung cancer combination therapy and entering a strategic partnership with Fujifilm for next-generation antibody-drug conjugate manufacturing.
Where is Taiho Pharmaceutical Co., Ltd., headquartered?
Taiho Pharmaceutical Co., Ltd., is headquartered in Chiyoda City, Tokyo.
When was Taiho Pharmaceutical Co., Ltd., founded?
Taiho Pharmaceutical Co., Ltd., was founded in 1963.
How big is Taiho Pharmaceutical Co., Ltd.,?
Taiho Pharmaceutical Co., Ltd., has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Taiho Pharmaceutical Co., Ltd., hold?
Taiho Pharmaceutical Co., Ltd., lists ISO 14001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
